Laparoscopic Splenectomy in Colorectal Cancer Patients with Chemotherapy-Associated Thrombocytopenia due to Hypersplenism
نویسندگان
چکیده
BACKGROUND Hypersplenism due to chemotherapy-related liver injury has been associated with severe thrombocytopenia that may preclude continuation of systemic therapy for cancer patients. Patients treated for metastatic colorectal cancer (mCRC) are among the most common patients affected by hypersplenism. Cessation of systemic therapy invariably leads to progression of disease. While partial splenic embolization has been employed successfully to reverse the effects of hypersplenism, the role of laparoscopic splenectomy for this problem has not been completely defined. METHODS A retrospective review was conducted of mCRC patients treated with laparoscopic splenectomy at our institution to reverse severe thrombocytopenia due to chemotherapy-related hypersplenism. An endpoint assessed was the ability to resume therapy after splenectomy. RESULTS Six patients with mCRC and hypersplenism requiring cessation of systemic therapy underwent laparoscopic splenectomy. All (6) patients had a postsurgical platelet count >150 × 10(3)/μl and resumed chemotherapy after surgery. Median platelet count prior to surgery was 66 × 10(3)/μl, and just prior to resuming systemic therapy it was 399.5 × 10(3)/μl. Median spleen size was 14.0 cm. There were no surgical complications. Mean hospital stay was 2.8 days and the median time from surgery to resumption of therapy was 23.5 days. CONCLUSIONS Laparoscopic splenectomy appears to offer selected patients with mCRC the opportunity to resume systemic therapy that otherwise would be discontinued due to thrombocytopenia from hypersplenism.
منابع مشابه
Laparoscopic Splenectomy in Pediatric Patients with Hematologic Diseases
OBJECTIVE The aim of this study was to evaluate our experience with laparoscopic splenectomy in pediatric patients with hematologic diseases. METHODS A retrospective chart review was performed to analyze the following: indication for splenectomy, pre- and peri-operative management, surgical technique, complications, duration of hospitalization, and outcome. RESULTS Eleven patients underwent...
متن کاملSarcoidosis of the spleen – rare indications for splenectomy. Own experience
The article presents two patients who underwent laparoscopic splenectomy because of splenic sarcoidosis. In one patient sarcoidosis was diagnosed based on the chest X-ray and computed tomography (CT) scans. Further imaging allowed for the diagnosis of systemic spread of the disease with bone marrow and splenic involvement. The latter location was confirmed by pathological examination after the ...
متن کاملSplenic Artery Embolization as a bridge to Splenectomy in severe Transfusion - Refractory Thrombocytopenia Secondary to Myelodysplastic Syndrome
Transfusion-refractory thrombocytopenia is an important clinical challenge in the treatment of patients with myelodysplastic syndrome. Hypersplenism can play a major role in splenic platelet sequestration and transfusion refractoriness, and though rare in myelodysplastic syndrome, it can commonly be seen in a wide range of other benign and malignant conditions. Splenectomy has been an effective...
متن کاملLaparoscopic RFA with splenectomy for hepatocellular carcinoma
BACKGROUND The treatment of hepatocellular carcinoma (HCC) is complicated and challenging because of the frequent presence of cirrhosis. Therefore, we propose a novel surgical approach to minimize the invasiveness and risk in patients with HCC, hypersplenism, and esophagogastric varices. METHODS This was a retrospective study carried out in 25 patients with HCC and hypersplenism and who under...
متن کاملRole of partial splenic arterial embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia.
BACKGROUND Hypersplenism is traditionally treated by surgical splenectomy. Transcatheter ablation of splenic parenchyma is an alternative treatment modality. METHODS We evaluated the efficacy and safety of partial splenic arterial embolization in 10 patients with chronic liver disease and hypersplenism with thrombocytopenia (platelet count <80,000/microL). RESULTS At six months follow up, m...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 5 شماره
صفحات -
تاریخ انتشار 2012